Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Influenza Vaccination: Integrating Best Practices and Optimizing Care to Reduce Disease Burden and Increase Vaccine Uptake
  • CME
  • CE

Credits Available
Physicians: maximum of 1.0 AMA PRA Category 1 Credit
Registered Nurses: 1.0 Nursing contact hour
Pharmacists: 1.0 contact hour (0.1 CEUs)
Released: October 21, 2022 Expiration: October 20, 2023
Start Activity
Provided by Clinical Care Options, LLC, in partnership with ProCE, LLC, and in collaboration with the Society of Infectious Diseases Pharmacists

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

 
Supported by an educational grant by
Seqirus USA Inc.
Paul G. Auwaerter, MD
person default
Rachel Macleod, PharmD, BCIDP, AAHIVP

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Describe the current and evolving landscape of seasonal influenza activity, particularly in relation to the impact of the COVID-19 pandemic
  • Compare available influenza vaccination formulations and identify optimization approaches based on seasonal and patient-specific factors
  • Apply effective strategies to improve influenza vaccination rates including identifying and addressing vaccine hesitancy

Information on this Educational Activity

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Faculty

Paul G. Auwaerter, MD

Sherrilyn and Ken Fisher Professor of Medicine
Clinical Director
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland

Paul G. Auwaerter, MD: consultant/advisor/speaker: EMD Serono, Humanigen, Pfizer; individual publicly traded stocks and stock options: Johnson & Johnson; investor: Wellstat.
Rachel Macleod, PharmD, BCIDP, AAHIVP

Clinical Pharmacy Specialist, Infectious Diseases
Department of Pharmacy
Ascension Genesys Hospital
Grand Blanc, Michigan

Rachel Macleod, PharmD, BCIDP, AAHIVP, has no relevant financial relationships to disclose.

Staff

Courtney Smith, PharmD, MS
Courtney Smith, PharmD, MS, has no relevant financial relationships to disclose.
Zachary Schwartz, MSc

Scientific Director

Zachary Schwartz, MSc, ELS, has no relevant financial relationships to disclose.
Ian Murphy, PhD
Ian Murphy, PhD, has no relevant financial relationships to disclose.
Julie Skowronski, NP
Julie Skowronski, NP, has no relevant financial relationships to disclose.
Quentin Minson, PharmD

Director of Educational Strategy

Quentin Minson, PharmD, has no relevant financial relationships to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Target Audience

This program is intended for physicians, nurses, pharmacists, and other HCPs who treat and manage patients at risk for influenza.

Goal

The goal of this activity is to improve and accelerate the awareness, understanding, and integration of current and emerging best practices in influenza vaccination.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Credit Designation

The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour.

Continuing Pharmacy Education

Credit Designation

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-22-264-H01-P.

Type of Activity: Application

Upon successfully completing the post-test with a score of 65% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.0 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from October 21, 2022, through October 20, 2023:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Influenza Vaccination: Integrating Best Practices and Optimizing Care to Reduce Disease Burden and Increase Vaccine Uptake
  • CME
  • CE

Loading...
Listen to expert faculty as they discuss best practices for reducing the burden of disease and increasing vaccine uptake.
Paul G. Auwaerter, MD
person default
Rachel Macleod, PharmD, BCIDP, AAHIVP
Physicians: maximum of 1.0 AMA PRA Category 1 Credit
Registered Nurses: 1.0 Nursing contact hour
Pharmacists: 1.0 contact hour (0.1 CEUs)
Released: October 21, 2022 Expiration: October 20, 2023

Related Content

Expert faculty discuss ways to improve the empiric treatment of HABP/VABP in the ICU in this commentary from Clinical Care Options (CCO)

person default Marion Elligsen, BScPhm, MSc, RPh, ACPR Keith S. Kaye, MD, MPH Andrew Shorr, MD, MPH, MBA Released: November 18, 2022

Learn from experts about strategies to improve timely, effective antibiotic therapy in patients with HABP/VABP at risk for multidrug resistance, from Clinical Care Options (CCO)

Clinical Care Options (CCO) presents expert faculty discussing RSV in certain adult populations and the development of RSV vaccines

John J. Russell, MD, FAAFP
Program Director
Laura Hurley, MD, MPH Pamela Rockwell, DO, FAAFP
Physicians: maximum of 1.5 AMA PRA Category 1 Credits Registered Nurses: 1.5 Nursing contact hours Released: October 28, 2022 Expired: October 27, 2023
Provided by Clinical Care Options, LLC, in partnership with ProCE, LLC, and in collaboration with the Society of Infectious Diseases Pharmacists

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

 
Supported by an educational grant by
Seqirus USA Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings